Igor V. Vladimirovych Cheretaev

Dr. Igor V. Vladimirovych Cheretaev

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Neuroscience and Behavioral Physiology
Verified
Journal Article
Closed access
PDF file
ICIgor V. Vladimirovych Cheretaev
Igor V. Vladimirovych Cheretaev
IKI. I. Korenyuk
I. I. Korenyuk
ANA. D. Nozdrachev
A. D. Nozdrachev

7 June 2018 in Neuroscience and Behavioral Physiology
Verified
Journal Article
Closed access
PDF file
ACA. V. Chaika
A. V. Chaika
DKD. R. Khusainov
D. R. Khusainov
ICIgor V. Vladimirovych Cheretaev
Igor V. Vladimirovych Cheretaev
IKI. I. Korenyuk
I. I. Korenyuk
ANA. D. Nozdrachev
A. D. Nozdrachev

16 December 2023 in Reviews on Clinical Pharmacology and Drug Therapy
Verified
Journal Article
Open access
MRMarina Yu. Ravaeva
Marina Yu. Ravaeva
ICIgor V. Vladimirovych Cheretaev
Igor V. Vladimirovych Cheretaev
ECElena N. Chuyan
Elena N. Chuyan
PGPavel A. Galenko-Yaroshevskii
Pavel A. Galenko-Yaroshevskii
EDElviza R. Dzheldubayeva
Elviza R. Dzheldubayeva
IMIrina S. Mironyuk
Irina S. Mironyuk
BACKGROUND: Changes in tissue oxidative metabolism under the action of stressors of different durations have not been studied. The relationship between NADH and FAD coenzymes and the microcirculatory bed remains unclear. AIM: This study aimed to identify the features of the reaction of skin microhemodynamics and tissue oxidative metabolism in rats exposed to acute and chronic stress factors of different durations and their combinations. MATERIALS AND METHODS: The experiment was performed on 100 male Wistar rats weighing 200–220 g. The animals were divided into five groups of 20 rats. The first control group and the second and third groups were exposed to acute stress (AS) and chronic hypokinetic stress (HS), respectively; the fourth group (AS-HS) was previously exposed to AS (on the first day) and then to HS (1–10 days); and the fifth group (for 10 days of the HS, then the effect of the AS on day 10). On day 10, the indicators of tissue oxidative metabolism and skin microhemodynamics were recorded. RESULTS: AS and HS increased the requirement of cells for ATP and contributed to the predominance of oxidative phosphorylation over other processes, as indicated by an increase in FAD. AS-HS significantly changed oxidative metabolism, separating oxidative phosphorylation and activating glycolysis. HS-AS did not cause such changes. AS increased the microcirculation index and reduced the coefficient of variation, and HS reduced the microcirculation index and increased the mean square deviation. AS–HS significantly increased the microcirculation index, and HS-AS increased the mean square deviation and coefficient of variation but reduced the microcirculation index. CONCLUSIONS: AS and HS increase the requirement of cells for ATP and contribute to the predominance of oxidative phosphorylation over other processes. AS-HS modifies oxidative metabolism by disconnecting oxidative phosphorylation and activating glycolysis. HS-AS depletes the metabolic reserves of the body. AS-HS rearranges metabolism along the path of glycolysis, protecting against stress factors and preventing the development of oxidative stress. AS leads to hyperemia and stasis of blood circulation in the microarray, reducing the vasomotor activity of the vessels. HS inhibits the level of tissue perfusion and reduces the inflow of arterial blood into the microcirculatory bed and the outflow of venous blood, leading to spastic, stagnant phenomena and stasis. AS-HS reduces vasoconstriction, preparing a microcirculatory bed for prolonged hypokinesia. HS-AS levels vasodilation and improves the parameters of skin microhemodynamics (mean square deviation and coefficient of variation).

27 May 2016 in Neuroscience and Behavioral Physiology
Verified
Journal Article
Closed access
PDF file
ICIgor V. Vladimirovych Cheretaev
Igor V. Vladimirovych Cheretaev
IKI. I. Korenyuk
I. I. Korenyuk
DKD. R. Khusainov
D. R. Khusainov
TGT. V. Gamma
T. V. Gamma
OKO. I. Kolotilova
O. I. Kolotilova
ANA. D. Nozdrachev
A. D. Nozdrachev

1 December 2017 in Izvestiya, Atmospheric and Oceanic Physics
Verified
Journal Article
Closed access
PDF file
NTN. A. Temuryants
N. A. Temuryants
KTK. N. Tumanyants
K. N. Tumanyants
DKD. R. Khusainov
D. R. Khusainov
ICIgor V. Vladimirovych Cheretaev
Igor V. Vladimirovych Cheretaev
ETE. N. Tumanyants
E. N. Tumanyants
It was found that moderate electromagnetic shielding, which attenuates constant and variable components of the geomagnetic field (19 h per day for 10 days), induces in male rats the development of...

1 January 2021 in Rossijskij fiziologičeskij žurnal im. I.M. Sečenova
Verified
Journal Article
Closed access
ЕЧЕ. Н. Чуян
Е. Н. Чуян
ИМИ. С. Миронюк
И. С. Миронюк
ICIgor V. Vladimirovych Cheretaev
Igor V. Vladimirovych Cheretaev
МРМ. Ю. Раваева
М. Ю. Раваева
ТГТ. В. Гришина
Т. В. Гришина
В современной литературе четко прослеживается возросший интерес к изучению биологических и терапевтических эффектов салицилатов. Крупные клинические испытания продемонстрировали эффективность ацетилсалициловой кислоты (АСК) и ее комплексных соединений в лечении и профилактике ишемической болезни сердца, хронической сердечной недостаточности, гипертонии и других заболеваний, что позволяет оценить широту благоприятных эффектов, оказываемых АСК на функционирование сердечно-сосудистой системы (ССС) и констатировать отсутствие в ближайшие годы других равноценных лекарственных средств. Важнейшим направлением остается расширение и усиление известной терапевтической активности (антипиретическая, анальгезирующая, противовоспалительная, антиоксидантная, антидепрессантная, противомигренозная, анксиолитическая и др.) на фоне снижения и/или ликвидации побочных эффектов, поскольку АСК занимает лидирующее положение среди всех нестероидных противовоспалительных препаратов по объемам применения и одно из первых мест по количеству побочных эффектов...